Health Care & Life Sciences » Pharmaceuticals | Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
8,202.00
38,184.00
43,016.00
26,121.00
25,496.00
25,034
Other Current Assets
429.00
852.00
3,343.00
1,019.00
947.00
1,022
Total Current Assets
8,631.00
39,036.00
46,359.00
27,140.00
26,443.00
26,056
Net Property, Plant & Equipment
45.00
328.00
350.00
150.00
91.00
43
Total Investments and Advances
60.00
133.00
189.00
89.00
89.00
100
Intangible Assets
-
-
120.00
120.00
120.00
120
Other Assets
-
45.00
-
11.00
11.00
-
Total Assets
8,736.00
39,542.00
47,018.00
27,510.00
26,754.00
26,319
ST Debt & Current Portion LT Debt
280.00
-
-
-
-
Accounts Payable
765.00
1,392.00
3,049.00
872.00
1,296.00
Other Current Liabilities
1,166.00
1,990.00
3,601.00
1,244.00
830.00
Total Current Liabilities
2,211.00
3,382.00
6,650.00
2,116.00
2,126.00
Other Liabilities
13.00
68.00
106.00
33.00
12.00
Total Liabilities
2,224.00
3,450.00
6,756.00
2,149.00
2,138.00
Common Equity (Total)
6,512.00
36,092.00
40,262.00
25,361.00
24,616.00
Total Shareholders' Equity
6,512.00
36,092.00
40,262.00
25,361.00
24,616.00
Total Equity
6,512.00
36,092.00
40,262.00
25,361.00
24,616.00
Liabilities & Shareholders' Equity
8,736.00
39,542.00
47,018.00
27,510.00
26,754.00

About Tonix Pharmaceuticals Holding

View Profile
Address
509 Madison Avenue
New York New York 10022
United States
Employees -
Website http://www.tonixpharma.com
Updated 07/08/2019
Tonix Pharmaceuticals Holding Corp. operates as a clinical-stage pharmaceutical company, which engages in the development of pharmaceutical products for public health challenges. It focuses on delivering an efficacious, and safe long-term treatment for posttraumatic stress disorder. It offers TNX-102 SL, TNX-601, TNX-801, TNX-301, and TNX-701.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.